A variant of nephrogenic diabetes insipidus: V2 receptor abnormality restricted to the kidney
- PMID: 1828422
- DOI: 10.1007/BF01955943
A variant of nephrogenic diabetes insipidus: V2 receptor abnormality restricted to the kidney
Abstract
In congenital nephrogenic diabetes insipidus (NDI) blunted responses of plasma factor VIII, von Willebrand factor, and plasminogen activator to the synthetic V2 analogue 1-desamino-8-D-arginine vasopressin (DDAVP) have been reported. In addition, vasodilatory responses to DDAVP appear to be absent in NDI. We describe a boy, who presented shortly after birth with the typical features of NDI, but who showed normal coagulation, fibrinolytic and vasodilatory responses to DDAVP. We conclude that in this patient the defect is confined to the kidney, while in other NDI patients there may be a general V2 receptor abnormality. These findings point to heterogeneity in NDI.
Similar articles
-
Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment.Pediatr Nephrol. 1992 Sep;6(5):476-82. doi: 10.1007/BF00874020. Pediatr Nephrol. 1992. PMID: 1457333 Review.
-
Nephrogenic diabetes insipidus: identification of the genetic defect.Pediatr Nephrol. 1993 Oct;7(5):685-8. doi: 10.1007/BF00852579. Pediatr Nephrol. 1993. PMID: 8251344 Review.
-
Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.N Engl J Med. 1988 Apr 7;318(14):881-7. doi: 10.1056/NEJM198804073181403. N Engl J Med. 1988. PMID: 2965301
-
1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.Neth J Med. 1993 Aug;43(1-2):5-12. Neth J Med. 1993. PMID: 8232694 Clinical Trial.
-
Normal homeostasis of fibrinolysis in nephrogenic diabetes insipidus in spite of defective V2- receptor-mediated responses of tissue plasminogen activator release.Eur J Clin Invest. 1990 Feb;20(1):72-8. doi: 10.1111/j.1365-2362.1990.tb01794.x. Eur J Clin Invest. 1990. PMID: 2138555
Cited by
-
Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene.Am J Hum Genet. 1994 Oct;55(4):648-52. Am J Hum Genet. 1994. PMID: 7524315 Free PMC article.
-
Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment.Pediatr Nephrol. 1992 Sep;6(5):476-82. doi: 10.1007/BF00874020. Pediatr Nephrol. 1992. PMID: 1457333 Review.
-
Nephrogenic diabetes insipidus: identification of the genetic defect.Pediatr Nephrol. 1993 Oct;7(5):685-8. doi: 10.1007/BF00852579. Pediatr Nephrol. 1993. PMID: 8251344 Review.
-
Discovery of aquaporins: a breakthrough in research on renal water transport.Pediatr Nephrol. 1995 Apr;9(2):228-34. doi: 10.1007/BF00860757. Pediatr Nephrol. 1995. PMID: 7540850 Review.
-
Aquaporin-2: new mutations responsible for autosomal-recessive nephrogenic diabetes insipidus-update and epidemiology.Clin Kidney J. 2012 Jun;5(3):195-202. doi: 10.1093/ckj/sfs029. Epub 2012 Mar 28. Clin Kidney J. 2012. PMID: 26069764 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Molecular Biology Databases